Revenue ₹4,517 Cr (+10% YoY)
Other
Tracked since Q3 FY26 - Q4 FY26
Biocon Limited
BIOCON
Needs more scored promises across 2 quarters
Biocon delivered a strong Q4 FY26, with adjusted revenue growth of 10% YoY and EBITDA up 29% YoY to ₹1,073 crore, dri...
Quarterly Earnings Timeline
Filing-verified financials, call summary, sentiment, and management-delivery signals by quarter.
Q4 FY26
15 May 2026
bullish
high
Revenue ₹4,517 Cr (+10% YoY)
Biocon delivered a strong Q4 FY26, with adjusted revenue growth of 10% YoY and EBITDA up 29% YoY to ₹1,073 crore, driven by favorable mix and operating leverage in bio...
Scorecard starts after historical backfill
Read full analysis →
Q3 FY26
10 Feb 2026
bullish
high
Revenue ₹4,173 Cr (+9% YoY)
Biocon delivered a solid Q3 FY26 with group revenue of ₹4,173 crore (+9% YoY) and EBITDA of ₹951 crore (+21% YoY), driven by strong biosimilar margins (28% vs 21% last...
Scorecard starts after historical backfill
Read full analysis →